Products

Vyzulta 0.024% Ophthalmic Solution is a prescription medication formulated to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. With its active ingredient, latanoprostene bunod, this ophthalmic solution provides effective IOP reduction.

Product Details

Key Features

• Prescription ophthalmic solution for IOP reduction.
• Contains latanoprostene bunod as the active ingredient.
• Designed for patients with open-angle glaucoma or ocular hypertension.

Active Ingredient

• Latanoprostene Bunod 0.024%

Administration

• Instill one drop into the affected eye(s) once daily in the evening or as directed by a healthcare professional.
• Use in accordance with the prescribed treatment plan.

How it Works

Vyzulta Ophthalmic Solution works by [insert brief explanation of the mechanism of action, if available].

Precautions

• Use only as directed by the product labeling or a healthcare professional.
• If irritation persists or increases, discontinue use and consult an eye care professional.

Packaging Information

• Available in a convenient dropper bottle.
• Each bottle contains a specific volume of Vyzulta Ophthalmic Solution.

*Disclaimer: The information provided here is not intended to endorse any specific medication, and it is essential to adhere to the regulations and guidelines set forth by healthcare authorities. Self-medication or the use of prescription medications without professional guidance can lead to serious health risks. Always consult with qualified healthcare professionals for personalized advice and follow recommended medical guidelines.*